Alain Dury

Title: The Innovative Contributions of Alain Dury

Introduction

Alain Dury is a notable inventor based in Ste-Catherine-de-la-Jacques-Cartier, Canada. He has made significant contributions to the field of medical science, particularly in the area of women's health. His work focuses on innovative solutions aimed at reducing health risks for postmenopausal women.

Latest Patents

Dury holds a patent for the invention titled "Reduction of the incidence or recurrence of breast cancer in postmenopausal women treated with intravaginal sex steroid precursor." This patent relates to the intravaginal use of sex steroid precursors, such as DHEA, to lower the incidence or recurrence of breast cancer in postmenopausal women. The recommended dosage is limited to 25 mg per day or less, and the patent also discloses the administration of selective estrogen receptor modulators for further reduction.

Career Highlights

Throughout his career, Alain Dury has been associated with Endorecherche, Inc., where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of hormone therapies and their applications in women's health.

Collaborations

Dury has collaborated with esteemed colleagues, including Fernand Labrie and Erick Moyneur. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Alain Dury's contributions to medical science, particularly in the realm of breast cancer prevention for postmenopausal women, highlight his dedication to improving women's health. His innovative patent and collaborative efforts underscore the importance of research in developing effective health solutions.